Denali Therapeutics Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for DNLI, updated each market day.
DNLI AI Sentiment
AI predicts Denali Therapeutics Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Denali Therapeutics Inc. Common Stock
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Sector
Exchange
Market Cap
$3,059,229,861
Cap Tier
Employees
503
Headquarters
SOUTH SAN FRANCISCO, CA
Listed Since
Dec. 8, 2017
DNLI Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
DNLI Volatility
Denali Therapeutics Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
